Cargando…

Predicting the Development of Renal Replacement Therapy Indications by Combining the Furosemide Stress Test and Chemokine (C-C Motif) Ligand 14 in a Cohort of Postsurgical Patients

Optimal timing of renal replacement therapy (RRT) initiation in severe acute kidney injury (AKI) remains controversial. Initiation of treatment early in the course of AKI may lead to some patients undergoing unnecessary RRT, whereas delayed treatment is associated with increased mortality. This stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Meersch, Melanie, Weiss, Raphael, Gerss, Joachim, Albert, Felix, Gruber, Janik, Kellum, John A., Chawla, Lakhmir, Forni, Lui G., Koyner, Jay L., von Groote, Thilo, Zarbock, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335738/
https://www.ncbi.nlm.nih.gov/pubmed/36988335
http://dx.doi.org/10.1097/CCM.0000000000005849
_version_ 1785071060711899136
author Meersch, Melanie
Weiss, Raphael
Gerss, Joachim
Albert, Felix
Gruber, Janik
Kellum, John A.
Chawla, Lakhmir
Forni, Lui G.
Koyner, Jay L.
von Groote, Thilo
Zarbock, Alexander
author_facet Meersch, Melanie
Weiss, Raphael
Gerss, Joachim
Albert, Felix
Gruber, Janik
Kellum, John A.
Chawla, Lakhmir
Forni, Lui G.
Koyner, Jay L.
von Groote, Thilo
Zarbock, Alexander
author_sort Meersch, Melanie
collection PubMed
description Optimal timing of renal replacement therapy (RRT) initiation in severe acute kidney injury (AKI) remains controversial. Initiation of treatment early in the course of AKI may lead to some patients undergoing unnecessary RRT, whereas delayed treatment is associated with increased mortality. This study aims to investigate whether the combination of the furosemide stress test (FST) and AKI-associated biomarkers can predict the development of indications for RRT. DESIGN: Single-center, prospective, observational study. SETTING: University Hospital of Muenster, Germany. PATIENTS: Critically ill, postoperative patients with moderate AKI (Kidney Disease: Improving Global Outcomes stage 2) and risk factors for further progression (vasopressors and/or mechanical ventilation) receiving an FST. INTERVENTIONS: Sample collection and measurement of different biomarkers (chemokine [C-C motif] ligand 14 [CCL14], neutrophil gelatinase-associated lipocalin, dipeptidyl peptidase 3). MEASUREMENT AND MAIN RESULTS: The primary endpoint was the development of greater than or equal to one predefined RRT indications (hyperkalemia [≥ 6 mmol/L], diuretic-resistant hypervolemia, high urea serum levels [≥ 150 mg/dL], severe metabolic acidosis [pH ≤ 7.15], oliguria [urinary output < 200 mL/12 hr], or anuria). Two hundred eight patients were available for the primary analysis with 108 having a negative FST (urine output < 200 mL in 2 hr following FST). Ninety-eight patients (47%) met the primary endpoint, 82% in the FST negative cohort. At the time of inclusion, the combination of a negative FST test and high urinary CCL14 levels had a significantly higher predictive value for the primary endpoint with an area under the receiver operating characteristic curve (AUC) of 0.87 (95% CI, 0.82–0.92) compared with FST or CCL14 alone (AUC, 0.79; 95% CI, 0.74–0.85 and AUC, 0.83; 95% CI, 0.77–0.89; p < 0.001, respectively). Other biomarkers showed lower AUCs. CONCLUSIONS: The combination of the FST with the renal biomarker CCL14 predicts the development of indications for RRT.
format Online
Article
Text
id pubmed-10335738
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-103357382023-07-12 Predicting the Development of Renal Replacement Therapy Indications by Combining the Furosemide Stress Test and Chemokine (C-C Motif) Ligand 14 in a Cohort of Postsurgical Patients Meersch, Melanie Weiss, Raphael Gerss, Joachim Albert, Felix Gruber, Janik Kellum, John A. Chawla, Lakhmir Forni, Lui G. Koyner, Jay L. von Groote, Thilo Zarbock, Alexander Crit Care Med Clinical Investigations Optimal timing of renal replacement therapy (RRT) initiation in severe acute kidney injury (AKI) remains controversial. Initiation of treatment early in the course of AKI may lead to some patients undergoing unnecessary RRT, whereas delayed treatment is associated with increased mortality. This study aims to investigate whether the combination of the furosemide stress test (FST) and AKI-associated biomarkers can predict the development of indications for RRT. DESIGN: Single-center, prospective, observational study. SETTING: University Hospital of Muenster, Germany. PATIENTS: Critically ill, postoperative patients with moderate AKI (Kidney Disease: Improving Global Outcomes stage 2) and risk factors for further progression (vasopressors and/or mechanical ventilation) receiving an FST. INTERVENTIONS: Sample collection and measurement of different biomarkers (chemokine [C-C motif] ligand 14 [CCL14], neutrophil gelatinase-associated lipocalin, dipeptidyl peptidase 3). MEASUREMENT AND MAIN RESULTS: The primary endpoint was the development of greater than or equal to one predefined RRT indications (hyperkalemia [≥ 6 mmol/L], diuretic-resistant hypervolemia, high urea serum levels [≥ 150 mg/dL], severe metabolic acidosis [pH ≤ 7.15], oliguria [urinary output < 200 mL/12 hr], or anuria). Two hundred eight patients were available for the primary analysis with 108 having a negative FST (urine output < 200 mL in 2 hr following FST). Ninety-eight patients (47%) met the primary endpoint, 82% in the FST negative cohort. At the time of inclusion, the combination of a negative FST test and high urinary CCL14 levels had a significantly higher predictive value for the primary endpoint with an area under the receiver operating characteristic curve (AUC) of 0.87 (95% CI, 0.82–0.92) compared with FST or CCL14 alone (AUC, 0.79; 95% CI, 0.74–0.85 and AUC, 0.83; 95% CI, 0.77–0.89; p < 0.001, respectively). Other biomarkers showed lower AUCs. CONCLUSIONS: The combination of the FST with the renal biomarker CCL14 predicts the development of indications for RRT. Lippincott Williams & Wilkins 2023-03-29 2023-08 /pmc/articles/PMC10335738/ /pubmed/36988335 http://dx.doi.org/10.1097/CCM.0000000000005849 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Investigations
Meersch, Melanie
Weiss, Raphael
Gerss, Joachim
Albert, Felix
Gruber, Janik
Kellum, John A.
Chawla, Lakhmir
Forni, Lui G.
Koyner, Jay L.
von Groote, Thilo
Zarbock, Alexander
Predicting the Development of Renal Replacement Therapy Indications by Combining the Furosemide Stress Test and Chemokine (C-C Motif) Ligand 14 in a Cohort of Postsurgical Patients
title Predicting the Development of Renal Replacement Therapy Indications by Combining the Furosemide Stress Test and Chemokine (C-C Motif) Ligand 14 in a Cohort of Postsurgical Patients
title_full Predicting the Development of Renal Replacement Therapy Indications by Combining the Furosemide Stress Test and Chemokine (C-C Motif) Ligand 14 in a Cohort of Postsurgical Patients
title_fullStr Predicting the Development of Renal Replacement Therapy Indications by Combining the Furosemide Stress Test and Chemokine (C-C Motif) Ligand 14 in a Cohort of Postsurgical Patients
title_full_unstemmed Predicting the Development of Renal Replacement Therapy Indications by Combining the Furosemide Stress Test and Chemokine (C-C Motif) Ligand 14 in a Cohort of Postsurgical Patients
title_short Predicting the Development of Renal Replacement Therapy Indications by Combining the Furosemide Stress Test and Chemokine (C-C Motif) Ligand 14 in a Cohort of Postsurgical Patients
title_sort predicting the development of renal replacement therapy indications by combining the furosemide stress test and chemokine (c-c motif) ligand 14 in a cohort of postsurgical patients
topic Clinical Investigations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335738/
https://www.ncbi.nlm.nih.gov/pubmed/36988335
http://dx.doi.org/10.1097/CCM.0000000000005849
work_keys_str_mv AT meerschmelanie predictingthedevelopmentofrenalreplacementtherapyindicationsbycombiningthefurosemidestresstestandchemokineccmotifligand14inacohortofpostsurgicalpatients
AT weissraphael predictingthedevelopmentofrenalreplacementtherapyindicationsbycombiningthefurosemidestresstestandchemokineccmotifligand14inacohortofpostsurgicalpatients
AT gerssjoachim predictingthedevelopmentofrenalreplacementtherapyindicationsbycombiningthefurosemidestresstestandchemokineccmotifligand14inacohortofpostsurgicalpatients
AT albertfelix predictingthedevelopmentofrenalreplacementtherapyindicationsbycombiningthefurosemidestresstestandchemokineccmotifligand14inacohortofpostsurgicalpatients
AT gruberjanik predictingthedevelopmentofrenalreplacementtherapyindicationsbycombiningthefurosemidestresstestandchemokineccmotifligand14inacohortofpostsurgicalpatients
AT kellumjohna predictingthedevelopmentofrenalreplacementtherapyindicationsbycombiningthefurosemidestresstestandchemokineccmotifligand14inacohortofpostsurgicalpatients
AT chawlalakhmir predictingthedevelopmentofrenalreplacementtherapyindicationsbycombiningthefurosemidestresstestandchemokineccmotifligand14inacohortofpostsurgicalpatients
AT forniluig predictingthedevelopmentofrenalreplacementtherapyindicationsbycombiningthefurosemidestresstestandchemokineccmotifligand14inacohortofpostsurgicalpatients
AT koynerjayl predictingthedevelopmentofrenalreplacementtherapyindicationsbycombiningthefurosemidestresstestandchemokineccmotifligand14inacohortofpostsurgicalpatients
AT vongrootethilo predictingthedevelopmentofrenalreplacementtherapyindicationsbycombiningthefurosemidestresstestandchemokineccmotifligand14inacohortofpostsurgicalpatients
AT zarbockalexander predictingthedevelopmentofrenalreplacementtherapyindicationsbycombiningthefurosemidestresstestandchemokineccmotifligand14inacohortofpostsurgicalpatients